Results 31 to 40 of about 17,687,028 (211)
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong [PDF]
postprint
Ho, PL +4 more
openaire +4 more sources
First Description of KPC-2-Producing Klebsiella oxytoca in Brazil [PDF]
ABSTRACT The present work reports the detection of the first case of nosocomial Klebsiella oxytoca producing class A carbapenemase KPC-2 in Brazil. The isolate KPN106 carried a 65-kb IncW-type plasmid that harbors the bla KPC gene and Tn 4401 b ...
Almeida, Anna C. S. +6 more
openaire +3 more sources
KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany [PDF]
Antimicrobial resistance due to carbapenemase expression poses a worldwide threat in healthcare. Inter-genus exchange of genetic information is of utmost importance in this context.Here, to the best of our knowledge, we describe the first detection and characterization of a KPC-2-producing Pseudomonas aeruginosa in Germany.Characterization of the ...
Jürgen Benjamin Hagemann +4 more
openaire +2 more sources
Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam [PDF]
ABSTRACT KPC-2 is the most prevalent class A carbapenemase in the world. Previously, KPC-2 was shown to hydrolyze the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam. In addition, substitutions at amino acid position R220 in the KPC-2 β-lactamase increased resistance to clavulanic acid.
Krisztina M, Papp-Wallace +3 more
openaire +2 more sources
Importation of KPC-2-producing Escherichia coli from India [PDF]
Sir, The production of carbapenem-hydrolysing b-lactamases is increasingly reported in Enterobacteriaceae. Among the different types of carbapenemases, the emergence of the Ambler class A KPC-type b-lactamases is of great concern, since those enzymes hydrolyse all b-lactams with the exception of cephamycins.
Potron, A. +3 more
openaire +2 more sources
A multidisciplinary approach to the design of novel inhibitors for KPC-2
Background. The emergence and dissemination of multi drug resistant (MDR) Gram-negative pathogens resistant to all available antibiotics poses a significant threat in clinical therapy. Among them, Klebsiella Pneumoniae clinical isolates overexpressing KPC-2 carbapenemase are the most worrisome, extending bacterial resistance to last resort carbapenems.
Celenza, Giuseppe +5 more
openaire +2 more sources
Yaping Han,1,2 Lei Huang,1,2 Chengcheng Liu,1,2 Xu Huang,3 Ruiying Zheng,1,2 Yanfei Lu,1,2 Wenying Xia,1,2 Fang Ni,1,2 Yaning Mei,1,2 Genyan Liu1,2 1Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing ...
Han Y +9 more
doaj
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan [PDF]
Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Clinical Laboratory Sciences and Medical Biotechnology, National ...
K.-P. Chung +5 more
openaire +1 more source
Qingping Zhou,1,* Chunyang Wu,2,* Peiyao Zhou,3 Ji Zhang,1 Zhanghua Xiong,4 Ying Zhou,5 Fangyou Yu5 1Department of Neurology, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006 ...
Zhou Q +6 more
doaj
KPC-derived organoid tumor histopathology features.
KPC-derived organoid tumor stained for hyaluronic acid (A), pimonidazole (B), collagen (green) and Meca32 (red) (C). Co-staining of pimonidazole (green) and Meca-32 (red) (D) showing vessels present in both oxic and hypoxic tissue. Black scale bar = 5 mm.
John L. Humm (8720559) +6 more
core +1 more source

